EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Evaluation of a Prediction-Based Bedtime Intervention in Reducing Nocturnal Low Glucose in Adults With Type 1 Diabetes: The DailyDose Bedtime Smart Snack Crossover Study

Clara Mosquera-Lopez iD, Valentina Roquemen-Echeverri, Peter G Jacobs iD, Katrina Ramsey, Joseph Pinsonault, Jae Eom, Hantao Ling, Daisy Chen, Deborah Branigan, Jessica R Castle, Korey K Hood iD, Melanie B Gillingham und 2 weitere

Diabetes Care · 2025

DOI: 10.2337/dc25-0407 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes Care, 2025. Verfasst von Clara Mosquera-Lopez und 13 weiteren Autor:innen. Beteiligte Einrichtung: Artificial Intelligence for Medical Systems Laboratory, Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Blood Glucose, Hypoglycemia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Division of Diabetes, Endocrinology, and Metabolic Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Nocturnal hypoglycemia is challenging for individuals with type 1 diabetes, particularly those who are physically active or using multiple daily injections (MDIs). We hypothesized that adding bedtime decision support to usual care with continuous glucose monitoring (CGM)–augmented MDI therapy could reduce nocturnal hypoglycemia. RESEARCH DESIGN AND METHODS We developed the DailyDose Smart Snack (DDSS) app, which features CGM and physical activity logging and delivers personalized bedtime snack recommendations to help prevent nocturnal hypoglycemia. Recommendations are based on the probability and timing of low-glucose events forecasted by an evidential neural network. We conducted a randomized crossover trial comparing DDSS with CGM-augmented MDI for 4 weeks each under free-living conditions to evaluate the feasibility and effect of DDSS in reducing nocturnal hypoglycemia. RESULTS Twenty participants completed the study (mean ± SD age 39 ± 15 years; 10 women; HbA1c 7.1% ± 1.0% [54 ± 11 mmol/mol]). There was no difference between arms in the proportion of nights with low-glucose events <70 mg/dL lasting ≥10 min (control 26.0% ± 14.1% vs. DDSS 23.6% ± 15.6%; odds ratio [OR] 0.83; P = 0.207) or in overnight CGM metrics. A post hoc analysis showed that the proportion of nights with low-glucose events <54 mg/dL lasting ≥10 min was significantly reduced in the DDSS arm by 3.5% (11.9% ± 12.9% vs. 8.3% ± 8.8%; OR 0.64; P = 0.040). CONCLUSIONS DDSS did not significantly reduce the proportion of nights with low-glucose events <70 mg/dL lasting ≥10 min but reduced nocturnal low glucose <54 mg/dL without compromising other glycemic metrics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Blood GlucoseHypoglycemiaHumansFemaleAdultMaleCross-Over StudiesMiddle AgedBlood Glucose Self-MonitoringHypoglycemic AgentsSnacksInsulin

Substanzen

Blood GlucoseHypoglycemic AgentsInsulin

Autor:innen und Institutionen

  • Artificial Intelligence for Medical Systems Laboratory, Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR.
  • School of Chemical, Biological and Environmental Engineering, Oregon State University, Corvallis, OR.
  • Biostatistics and Design Program, Oregon Health & Science University, Portland, OR.
  • Harold Schnitzer Diabetes Health Center, Division of Endocrinology, Department of Medicine, Oregon Health & Science University, Portland, OR.
  • Stanford Diabetes Research Center, School of Medicine, Stanford University, Stanford, CA.
  • Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR.

ORCID-Profile: Clara Mosquera-Lopez, Peter G Jacobs, Korey K Hood, Leah M Wilson

Förderung

  • NIDDK NIH HHS
  • Division of Diabetes, Endocrinology, and Metabolic Diseases

Zitieren

APA

Mosquera-Lopez, C., Roquemen-Echeverri, V., Jacobs, P. G., Ramsey, K., Pinsonault, J., Eom, J., Ling, H., Chen, D., Branigan, D., Castle, J. R., Hood, K. K., Gillingham, M. B., Aby-Daniel, D., & Wilson, L. M. (2025). Evaluation of a Prediction-Based Bedtime Intervention in Reducing Nocturnal Low Glucose in Adults With Type 1 Diabetes: The DailyDose Bedtime Smart Snack Crossover Study. Diabetes Care. https://doi.org/10.2337/dc25-0407

Vancouver

Mosquera-Lopez C, Roquemen-Echeverri V, Jacobs PG, Ramsey K, Pinsonault J, Eom J, et al. Evaluation of a Prediction-Based Bedtime Intervention in Reducing Nocturnal Low Glucose in Adults With Type 1 Diabetes: The DailyDose Bedtime Smart Snack Crossover Study. Diabetes Care. 2025. doi:10.2337/dc25-0407

BibTeX
@article{MosqueraLopez2025,
  author = {Mosquera-Lopez, Clara and Roquemen-Echeverri, Valentina and Jacobs, Peter G and Ramsey, Katrina and Pinsonault, Joseph and Eom, Jae and Ling, Hantao and Chen, Daisy and Branigan, Deborah and Castle, Jessica R and Hood, Korey K and Gillingham, Melanie B and Aby-Daniel, Diana and Wilson, Leah M},
  title = {Evaluation of a Prediction-Based Bedtime Intervention in Reducing Nocturnal Low Glucose in Adults With Type 1 Diabetes: The DailyDose Bedtime Smart Snack Crossover Study},
  journal = {Diabetes Care},
  year = {2025},
  doi = {10.2337/dc25-0407}
}
Kostenlos starten →